Poultry Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Poultry Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of the Poultry Diagnostics Market

The Poultry Diagnostics market size was valued at USD 920.4 million in 2023, and the market is now projected to grow from USD 978.2 million in 2024 to USD 2303.4 million by 2032, exhibiting a CAGR of 11.3% during the forecast period of 2024-2032.

The COVID-19 pandemic had a combined effect on the Poultry Diagnostics market, characterized with the aid of initial disruptions accompanied by recuperation and Poultry Diagnostics market growth. In the early ranges, lockdown measures, deliver chain disruptions, and reduced purchaser calls for affected hen manufacturing and diagnostic trying out sports. However, because the pandemic improved, the importance of food safety and animal health became increasingly obvious, riding the demand for diagnostic testing to screen and manage sicknesses which include avian influenza and Newcastle sickness.

The Poultry Diagnostics market share is mainly driven by growing international demand for hen products, coupled with the rising occurrence of infectious diseases in fowl populations. As the hen industry keeps increasing to meet developing meal needs, there may be a heightened recognition of ensuring animal health, welfare, and productiveness. This drives the want for advanced diagnostic solutions to accurately detect and monitor sicknesses, enabling well-timed intervention and management measures.

Several tendencies are shaping the Poultry Diagnostics market. Firstly, there's a notable shift toward the adoption of fast diagnostic tests, consisting of polymerase chain reaction (PCR) and lateral drift assays, for brief and accurate detection of rooster sicknesses, facilitating activation intervention and manipulation measures. Secondly, there may be a growing consciousness of multiplex trying out platforms that enable simultaneous detection of more than one pathogens, improving performance and cost-effectiveness in disease monitoring.

Comprehensive Analysis of the Poultry Diagnostics Market

The Poultry Diagnostics marketplace is segmented primarily based on product kind, check type, disorder type, and cease-user. Product types include diagnostic kits, reagents, gadgets, and offerings, catering to diverse trying-out wishes. Test kinds vary from serological exams to molecular diagnostics, each providing unique blessings in detecting a huge range of poultry diseases. Disease kinds embody viral, bacterial, and parasitic diseases in chicken populations. End-customers span throughout chicken farms, veterinary clinics, diagnostic laboratories, and research institutes, reflecting the numerous stakeholders worried about poultry health management.

North America emerges as the leading location inside the Poultry Diagnostics market, attributable to its superior healthcare infrastructure, stringent regulatory standards, and full-size investments in studies and improvement. The vicinity's robust emphasis on meals protection and animal health, coupled with a excessive incidence of fowl illnesses, drives the demand for superior diagnostic solutions. Additionally, the presence of key market gamers and studies establishments similarly strengthens North America's role as a frontrunner in the global poultry diagnostics marketplace.

Some of the pinnacle gamers within the Poultry Diagnostics marketplace, alongside their headquarters, consist of IDEXX Laboratories, Inc. (USA); Zoetis Inc. (USA); Thermo Fisher Scientific Inc. (USA); Qiagen N.V. (Netherlands); BioChek BV (Netherlands); and Bio-Rad Laboratories, Inc. (California, USA). These agencies are renowned for their sizeable portfolios of diagnostic merchandise, offerings, and answers catering to the hen industry's diverse needs globally.

In March 2023, Zoetis Inc. Announced the outing of its brand new Avian Influenza Virus RealPCR Test, a molecular diagnostic answer constructed to look for avian influenza viruses in birds increasingly and with success. This upgrade marked a big development in the bird diagnostics market, imparting veterinarians and poultry producers an important device for timely finding out and manipulation of avian influenza outbreaks, thereby helping to defend hen health and mitigate monetary losses inside the industry.

Segmentation Table

Global Poultry Diagnostics Market Scope

Study Period 2019-2032

Base Year 2023

Forecast Period 2024-2032

Growth Rate CAGR of 11.3% from 2024-2032

Historical Period 2019-2022

Unit Value (USD Billion)

Segmentation By product, technology, disease indication, end-user and Region

By product Instruments

Consumables and kits

By technology

Enzyme-linked immunosorbent assay

Polymerase chain reaction

Immunofluorescent assay

Hemagglutination assay

others

By disease indicationavian salmonellosis

avian influenza

Newcastle disease

Mycoplasma

Infectious bursal disease

others

By end-userveterinary hospitals and clinics

Veterinary diagnostics laboratories

others

By Region North America (By product, technology, disease indication, end-user and Region)

- U.S.

- Canada

Europe (By product, technology, disease indication, end-user and Region)

- U.K.

- Germany

- France

- Italy

- Spain

- Scandinavia

- Rest of Europe

Asia Pacific (By product, technology, disease indication, end-user and Region)

- China

- Japan

- India

- Australia

- Southeast Asia

- Rest of Asia Pacific

Latin America (By product, technology, disease indication, end-user and Region)

- Brazil

- Mexico

- Rest of Latin America

Middle East & Africa (By product, technology, disease indication, end-user and Region)

- GCC

- South Africa

- Rest of Middle East & Africa


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Number of Clinical Trials Conducted by Key Countries/ Regions, 2022
4.2. Overview: Start-ups and Innovations in the Contract Research Organization (CRO) Services Market
4.3. Insights on Renal Diseases Research
4.4. Key Industry Developments – Mergers, Acquisitions, and Partnerships
4.5. Impact of COVID-19 on the Market
5. Global Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2019-2030
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Service Type
5.2.1. Early Phase Development Services
5.2.1.1. CMC
5.2.1.2. Preclinical Services
5.2.1.3. Discovery
5.2.2. Clinical
5.2.2.1. Phase 1
5.2.2.2. Phase 2
5.2.2.3. Phase 3
5.2.2.4. Phase 4
5.2.3. Laboratory Services
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Oncology
5.3.2. CNS
5.3.3. Cardiology
5.3.4. Infectious Disease
5.3.5. Metabolic Disorders
5.3.6. Renal/Nephrology
5.3.7. Others
5.4. Market Analysis, Insights and Forecast – By End-user
5.4.1. Pharmaceutical & Biotechnological Companies
5.4.2. Medical Device Companies
5.4.3. Academic & Research Institutes
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Rest of the World
6. North America Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2019-2030
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Service Type
6.2.1. Early Phase Development Services
6.2.1.1. CMC
6.2.1.2. Preclinical Services
6.2.1.3. Discovery
6.2.2. Clinical
6.2.2.1. Phase 1
6.2.2.2. Phase 2
6.2.2.3. Phase 3
6.2.2.4. Phase 4
6.2.3. Laboratory Services
6.2.4. Others
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1. Oncology
6.3.2. CNS
6.3.3. Cardiology
6.3.4. Infectious Disease
6.3.5. Metabolic Disorders
6.3.6. Renal/Nephrology
6.3.7. Others
6.4. Market Analysis, Insights and Forecast – By End-user
6.4.1. Pharmaceutical & Biotechnological Companies
6.4.2. Medical Device Companies
6.4.3. Academic & Research Institutes
6.4.4. Others
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2019-2030
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Service Type
7.2.1. Early Phase Development Services
7.2.1.1. CMC
7.2.1.2. Preclinical Services
7.2.1.3. Discovery
7.2.2. Clinical
7.2.2.1. Phase 1
7.2.2.2. Phase 2
7.2.2.3. Phase 3
7.2.2.4. Phase 4
7.2.3. Laboratory Services
7.2.4. Others
7.3. Market Analysis, Insights and Forecast – By Application
7.3.1. Oncology
7.3.2. CNS
7.3.3. Cardiology
7.3.4. Infectious Disease
7.3.5. Metabolic Disorders
7.3.6. Renal/Nephrology
7.3.7. Others
7.4. Market Analysis, Insights and Forecast – By End-user
7.4.1. Pharmaceutical & Biotechnological Companies
7.4.2. Medical Device Companies
7.4.3. Academic & Research Institutes
7.4.4. Others
7.5. Market Analysis – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia pacific Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2019-2030
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Service Type
8.2.1. Early Phase Development Services
8.2.1.1. CMC
8.2.1.2. Preclinical Services
8.2.1.3. Discovery
8.2.2. Clinical
8.2.2.1. Phase 1
8.2.2.2. Phase 2
8.2.2.3. Phase 3
8.2.2.4. Phase 4
8.2.3. Laboratory Services
8.2.4. Others
8.3. Market Analysis, Insights and Forecast – By Application
8.3.1. Oncology
8.3.2. CNS
8.3.3. Cardiology
8.3.4. Infectious Disease
8.3.5. Metabolic Disorders
8.3.6. Renal/Nephrology
8.3.7. Others
8.4. Market Analysis, Insights and Forecast – By End-user
8.4.1. Pharmaceutical & Biotechnological Companies
8.4.2. Medical Device Companies
8.4.3. Academic & Research Institutes
8.4.4. Others
8.5. Market Analysis – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. South Korea
8.5.6. Southeast Asia
8.5.7. Rest of Asia Pacific
9. Rest of the World Contract Research Organization (CRO) Services Market Analysis, Insights and Forecast, 2019-2030
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Service Type
9.2.1. Early Phase Development Services
9.2.1.1. CMC
9.2.1.2. Preclinical Services
9.2.1.3. Discovery
9.2.2. Clinical
9.2.2.1. Phase 1
9.2.2.2. Phase 2
9.2.2.3. Phase 3
9.2.2.4. Phase 4
9.2.3. Laboratory Services
9.2.4. Others
9.3. Market Analysis, Insights and Forecast – By Application
9.3.1. Oncology
9.3.2. CNS
9.3.3. Cardiology
9.3.4. Infectious Disease
9.3.5. Metabolic Disorders
9.3.6. Renal/Nephrology
9.3.7. Others
9.4. Market Analysis, Insights and Forecast – By End-user
9.4.1. Pharmaceutical & Biotechnological Companies
9.4.2. Medical Device Companies
9.4.3. Academic & Research Institutes
9.4.4. Others
10. Competitive Analysis
10.1. Global Market Share Analysis (2022)
10.2. Company Profiles
10.2.1. Pharmaceutical Product Development, LLC
10.2.2. Medpace Holdings, Inc.
10.2.3. Iqvia
10.2.4. ICON plc
10.2.5. KCR SA
10.2.6. PSI
10.2.7. Parexel International Corporation
10.2.8. Labcorp Drug Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings